Holen Sie sich die Stockscreener-App
0.9184
2.07%
-0.0194
Handel nachbörslich:
.92
0.0016
+0.17%
Schlusskurs vom Vortag:
$0.9378
Offen:
$0.9378
24-Stunden-Volumen:
1.25M
Relative Volume:
0.33
Marktkapitalisierung:
$359.52M
Einnahmen:
$86.26M
Nettoeinkommen (Verlust:
$-50.08M
KGV:
-3.7501
EPS:
-0.2449
Netto-Cashflow:
$-94.48M
1W Leistung:
+0.60%
1M Leistung:
+4.23%
6M Leistung:
-40.36%
1J Leistung:
-31.97%
1-Tages-Spanne:
$0.9027
$0.9661
1-Wochen-Bereich:
$0.8333
$0.9661
52-Wochen-Spanne:
$0.7029
$1.72
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
50 MILK STREET, BOSTON
Compare LAB vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
0.9184 | 359.52M | 86.26M | -50.08M | -94.48M | -0.2449 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders - AOL.com
Standard BioTools Inc. (LAB) Surges 5% as Stock Approaches Key Resistance LevelOvernight Profile - dars.gov.et
Standard BioTools (LAB) Surges 5.36% as Shares Test Key Resistance LevelWave Truncation - dars.gov.et
Enterprise value to revenue forward of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Price to earnings forward of Standard BioTools Inc. – BOATS:LAB - TradingView
Enterprise value to EBITDA forward of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Price to book forward of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Price to sales forward of Standard BioTools Inc. – BOATS:LAB - TradingView
Form 4 Standard Biotools Inc For: 23 June - Investing.com UK
Form 4 Standard Biotools Inc For: 23 June By Investing.com - Investing.com Australia
Standard BioTools (LAB) director receives new RSU and stock option awards - Stock Titan
Standard BioTools (LAB) awards 500,000 RSUs to chief business officer - Stock Titan
STANDARD BIOTOOLS (LAB) director Frank Witney receives new RSU and stock option awards - Stock Titan
Eli Casdin (LAB) granted RSUs and stock options, reports large fund holdings - Stock Titan
STANDARD BIOTOOLS (NASDAQ: LAB) director receives new RSU and stock option awards - Stock Titan
STANDARD BIOTOOLS (NASDAQ: LAB) director awarded RSUs and stock options in new Form 4 - Stock Titan
Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024. - marketscreener.com
Standard BioTools Inc (LAB) Institutional Confidence - TradingKey
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AstroNova, Inc. (Nasdaq – ALOT), Open Lending Corporation (Nasdaq – LPRO), Huntsman Corporation (NYSE – HUN), Standard BioTools Inc. (Nasdaq – LAB - The Malone Telegram
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AstroNova, Inc. (Nasdaq – ALOT), Open Lending Corporation (Nasdaq – LPRO), Huntsman Corporation (NYSE – HUN), Standard BioTools Inc. (Nasdaq – LAB) - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Standard BioTools Shareholders Approve 2026 Equity Incentive Plans - TipRanks
Standard BioTools (LAB) investors approve 2026 equity plan and ESPP share increase - Stock Titan
Standard BioTools Inc (LAB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Standard BioTools Inc (LAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Standard BioTools Inc (LAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Standard BioTools Inc (LAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Standard BioTools Inc (LAB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Standard BioTools Inc (LAB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Standard BioTools Inc (LAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Standard BioTools Inc (LAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Standard BioTools (LAB) Slides 3.65% as Biotech Sector Faces HeadwindsNAAIM Leverage - newsline.com
Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders? - TradingView
Viking backs Standard BioTools (LAB) merger with Treeline Biosciences - Stock Titan
Viking Global Investors Enters Voting Pact at Standard BioTools with 15.0% Stake - TradingView
Casdin funds deepen tie to Standard BioTools (LAB) with 23.9% stake and Treeline merger support - Stock Titan
Company that shut down Peninsula HQ now swept up in reverse merger - The Business Journals
Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings - Sahm
Stealthy startup Treeline plans a reverse merger - BioPharma Dive
Standard BioTools to merge with Treeline in biotech transformation deal - The Pharma Letter
Standard BioTools Inc. (LAB) Discusses Merger and Strategic RationaleSlideshow (NASDAQ:LAB) 2026-06-08 - Seeking Alpha
Standard BioTools (LAB) Plunges Over 30%, Testing Critical Support at $0.76Put Dominated - lwvtexas.org
Standard BioTools and Treeline Biosciences anno... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Standard BioTools and Treeline Biosciences Announce $900M Merger to Form Public Biopharma Company Focused on Oncology and Precision Medicines 12 - Minichart
Standard BioTools to Merge with Treeline Biosciences - TipRanks
Standard BioTools (NASDAQ: LAB) to merge with Treeline in $2.5B exchange‑ratio deal - Stock Titan
Standard BioTools to Merge With Treeline in All-Stock Deal Valuing Treeline at $2.5 Billion - TradingView
Treeline Biosciences, Standard BioTools (NASDAQ: LAB) plan all-stock merger - Stock Titan
Standard BioTools and Treeline Biosciences Agree to Merger, Creating Well-Funded Clinical-Stage Biopharma Company - citybiz
Standard BioTools, Treeline Biosciences to Merge in All-Stock Deal - marketscreener.com
Standard BioTools to merge with Treeline Biosciences By Investing.com - Investing.com Nigeria
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):